WuXi AppTec Executive and Leadership Team

Ge Li, the Chief Executive Officer at WuXi AppTec, directs the overarching corporate strategy and long-term vision for the global research and manufacturing platform. Ge Li architects the expansion of integrated service models that support small molecule drug development and advanced therapies across international markets. By fostering a culture of innovation, the Chief Executive Officer ensures the company maintains a competitive edge in the complex pharmaceutical landscape. This leadership role involves constant engagement with global stakeholders to align service capabilities with evolving industry demands. Through the oversight of diverse business segments, the Chief Executive Officer drives operational excellence and sustainable growth. Ultimately, the Chief Executive Officer secures the company's position as a critical partner for pharmaceutical and biotech organizations seeking to accelerate the discovery and commercialization of novel medical treatments on a global scale.

Steve Yang, the Co-Chief Executive Officer at WuXi AppTec, manages the execution of global business strategies and cross-functional integration across the company's diverse service segments. Steve Yang drives the alignment of research and development initiatives with the specific needs of international clients, ensuring seamless project delivery from discovery to commercialization. By optimizing internal processes, the Co-Chief Executive Officer enhances the efficiency of the platform's biology and chemistry services. This leadership role requires close collaboration with the executive team to scale operations in key markets including the United States and Europe. Through the implementation of rigorous quality standards, the Co-Chief Executive Officer supports the rapid advancement of candidate selection and clinical development. Ultimately, the Co-Chief Executive Officer strengthens the company's operational framework to facilitate the successful delivery of complex synthetic molecular modalities for global partners.

Minzhang Chen, the Executive Vice President of Wuxi Apptec and Chief Executive Officer of Wuxi Sta at WuXi AppTec, oversees the comprehensive manufacturing and development services for small molecule drugs and complex conjugates. Minzhang Chen directs the scaling of contract development and manufacturing organization capabilities to meet the high-volume requirements of global pharmaceutical clients. By managing the integration of advanced synthetic technologies, the Executive Vice President of Wuxi Apptec and Chief Executive Officer of Wuxi Sta ensures the delivery of high-quality, cost-effective manufacturing solutions. This leadership role involves coordinating large-scale production facilities to support projects from early-stage development through commercial launch. Through the optimization of supply chain and production workflows, the Executive Vice President of Wuxi Apptec and Chief Executive Officer of Wuxi Sta drives significant revenue growth and operational efficiency. Ultimately, the Executive Vice President of Wuxi Apptec and Chief Executive Officer of Wuxi Sta maintains the company's reputation for excellence in pharmaceutical manufacturing.

Florence Shi, the Senior Vice President, Chief Financial Officer at WuXi AppTec, directs the financial strategy, capital allocation, and fiscal reporting for the entire organization. Florence Shi oversees the management of financial risks and ensures the company maintains a strong balance sheet to support ongoing investments in research and manufacturing infrastructure. By providing critical financial insights, the Senior Vice President, Chief Financial Officer enables the executive team to make informed decisions regarding market expansion and service diversification. This leadership role involves managing investor relations and ensuring compliance with international financial regulations across all operating regions. Through the optimization of financial planning and analysis, the Senior Vice President, Chief Financial Officer supports the company's long-term growth objectives and profitability. Ultimately, the Senior Vice President, Chief Financial Officer secures the financial health of the organization, allowing for the continued advancement of drug discovery and development services on a global scale.

Zhaohui Zhang, the Executive Vice President & Chief Operating Officer (China) at WuXi AppTec, manages the day-to-day operational activities and infrastructure across the company's primary research and manufacturing hubs in China. Zhaohui Zhang directs the implementation of standardized operational protocols to ensure consistency and quality across all domestic business segments. By overseeing the deployment of resources and talent, the Executive Vice President & Chief Operating Officer (China) supports the seamless execution of integrated projects from target discovery to candidate selection. This leadership role involves maintaining high levels of productivity and safety within the laboratory and manufacturing environments. Through the continuous improvement of operational workflows, the Executive Vice President & Chief Operating Officer (China) enhances the company's ability to meet the rigorous timelines of global drug development. Ultimately, the Executive Vice President & Chief Operating Officer (China) ensures that the domestic operational foundation remains robust and scalable for future growth.

Xiaozhong Liu, the Executive VP & Head of the Strategic Project Office at WuXi AppTec, directs the planning and execution of high-priority initiatives that align with the company's long-term strategic goals. Xiaozhong Liu oversees the coordination of cross-functional teams to ensure the successful delivery of complex, multi-segment projects that span the entire drug development lifecycle. By identifying and mitigating potential bottlenecks, the Executive VP & Head of the Strategic Project Office enhances the speed and efficiency of project completion for global clients. This leadership role involves working closely with the C-suite to translate corporate vision into actionable project roadmaps. Through the rigorous monitoring of project milestones and performance metrics, the Executive VP & Head of the Strategic Project Office drives continuous improvement across the organization. Ultimately, the Executive VP & Head of the Strategic Project Office ensures that strategic projects remain on track to support the company's mission of accelerating global medical innovation.